Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
RESEARCH TOOLSreports
Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Stock Price & Analysis
3 Followers
GZPHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.29 - $3.18
Previous Close$2.67
Volume2.00K
Average Volume (3M)N/A
Market Cap
$6.31B
Enterprise Value$4.99B
Total Cash (Recent Filing)¥22.56B
Total Debt (Recent Filing)¥11.43B
Price to Earnings (P/E)7.6
Beta0.08
Next Earnings
Aug 18, 2024EPS Estimate
$0.07Last Dividend Ex-Date
Jun 13, 2024Dividend Yield3.98%
Share Statistics
EPS (TTM)0.35
Shares Outstanding219,900,000
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.13
R-Squared0.00158
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.25Price Target Upside12.85% Upside
Rating ConsensusHold
Number of Analyst Covering1
Guangzhou Baiyunshan Pharmaceutical Holdings Company News
PremiumCompany Announcements
Guangzhou Baiyunshan Welcomes New Investment Partner
PremiumCompany Announcements
Baiyunshan’s Subsidiary Clears Generic Drug EvaluationPremiumCompany Announcements
Guangzhou Baiyunshan Subsidiary Targets NEEQ Listing
PremiumCompany Announcements
Guangzhou Baiyunshan Declares Year-End DividendPremiumCompany Announcements
Guangzhou Baiyunshan Concludes Key 2024 MeetingsPremiumCompany Announcements
Guangzhou Baiyunshan Announces Shareholders’ MeetingsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
4.21% Mutual Funds
2.02% Other Institutional Investors
93.76% Public Companies and
Individual Investors
GZPHF FAQ
What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price range in the past 12 months?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H lowest stock price was $2.29 and its highest was $3.18 in the past 12 months.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s market cap?
Currently, no data Available
When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s upcoming earnings report date is Aug 18, 2024 which is in 32 days.
How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s earnings last quarter?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H released its earnings results on Apr 26, 2024. The company reported $0.166 earnings per share for the quarter, beating the consensus estimate of $0.096 by $0.069.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H overvalued?
According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price is currently Undervalued.
Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pay dividends?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H pays a Annually dividend of $0.11 which represents an annual dividend yield of 3.98%. See more information on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H dividends here
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s EPS estimate is $0.07.
How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H have?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H has 219,900,000 shares outstanding.
What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price movement after its last earnings report?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H reported an EPS of $0.166 in its last earnings report, beating expectations of $0.096. Following the earnings report the stock price went up 0.752%.
Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?
Currently, no hedge funds are holding shares in GZPHF
---
Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.86%
12-Months-Change
Fundamentals
Return on Equity
11.40%
Trailing 12-Months
Asset Growth
1.59%
Trailing 12-Months
Company Description
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its operations are divided into three main segments: pharmaceutical manufacturing, pharmaceutical distribution & retail, and health products. The greater portion of its revenue comes from its pharmaceutical activities in patent medicine, raw materials, distribution, and retail. The rest of its revenues come from its beverage, food, cosmetics, and health products. The company's primary market is China.
---
GZPHF Stock 12 Month Forecast
Average Price Target
$3.25
▲(12.85% Upside)
Technical Analysis
---